Brought to you by:
The kids are alright
“I know I gotta get away and I know if I don’t, I’ll go out of my mind; better leave her behind with the kids, they’re alright, the kids are alright.” – Pete Townshend, The Who Mankind harnesses the power…
Long-term VQI-VISION analysis sheds light on PVI versus bypass in aortoiliac occlusive disease
Today’s Plenary Session 4—Hosted in Great Hall A, First Floor from 10:45 a.m.–12 p.m.—will feature a presentation of five-year findings from the VQI-VISION database indicating that aortobifemoral bypass (ABF) remains a more durable long-term treatment option compared to endovascular intervention…
Vascular trainees better prepared for open aortic practice than commonly reported, new study shows
Current graduates from both vascular surgery residency and fellowship programs are well prepared for surgical practice in aortic disease whether they are performing open repair or endovascular therapy, contrasting with research indicating that trainees are entering the workforce with inadequate…
The endovascular revolution and open aortic training: ‘It’s not necessarily a crisis but it could become one’
Jean Panneton, MD, considers himself what he terms a “blue-collar” vascular surgeon as much as one engaged in academic practice and the necessity of helping contribute to the next generation of vascular surgeons. He operates. And he operates a lot.…
UK-COMPASS: Aortas, open surgical skills and gratitude
As you read this, you are probably wondering why the heck I am writing an editorial on complex aortic aneurysms when you know I am somewhere in the South focused on vascular trauma and limb ischemia. Well, no good deed…
‘What if we could translate the most durable Dacron repair into a minimally invasive approach?’
Imagine a world in which the enduring Dacron graft, birthed by vascular pioneer Michael DeBakey, MD, some 70 years ago as an open repair for aortic aneurysms, could be performed minimally invasively with the sorts of gains associated with endovascular…
BEST-CLI: A year down the road
A dedicated session at the 2023 VEITHsymposium (Nov. 14–18) in New York City aimed to unpack the ways in which clinical practice and attitudes in the field of chronic limb-threatening ischemia (CLTI) have changed since the BEST-CLI trial was published…
First patient treated in ARISE II study of ascending stent graft
Gore has announced the first patient implantation of the company’s ascending stent graft in the ARISE II trial, describing this as an exciting step in the development of treatments for pathologies involving the ascending aorta using endovascular repair rather than…
Preventing spinal cord ischemia: Novel techniques for direct segmental artery revascularization show promise, WVS 2023 hears
A vascular surgery team from the University of Southern California (USC) in Los Angeles demonstrated the feasibility of multidisciplinary direct revascularization of segmental arteries to prevent spinal cord ischemia (SCI) using novel endovascular or extra-anatomic bypass techniques in high-risk patients…
NESVS 2022: Study illustrates relationship between increased distance from medical center and higher treatment costs among complex aortic patients
Research detailing that patients traveling farther for complex aortic surgery have higher procedural costs, postoperative imaging costs, and comprehensive one-year costs was among the new science being presented at the 2022 annual meeting of the New England Society for Vascular…